News
UCLA Founded Medical Device Company reaches $52.5M Series B Financing
Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy
PR Newswire
Call for Entries Pearl Cohen Poster Competition
Call for Poster Entries - Deadline April 10th!
UCLA TDG Innovation Magazine Winter 2025
UCLA TDG Innovation Magazine Winter 2025
In this year end wrap-up, you will find:
UCLA Ventures at JP Morgan - January 13th, 2026
Join us for UCLA's Investor Pitch Showcase at JPM, featuring top innovation and technology.
January 13th 2026 | 3:30 - 6:30pm | 425 Market St.
Rarity PBC Secures Exclusive License from UCLA TDG to Advance a Life-Saving Gene Therapy for ADA-SCID
For Immediate Release
Experienced Thought Leaders Join UCLA TDG Board of Directors
Experienced Thought Leaders Join UCLA Technology Development Group Board of Directors
Los Angeles, CA – [Monday, October 6, 2025] – UCLA Technology Development Corp (UCLA TDC) is excited to announce the addition of three highly accomplished leaders to its Board of Directors: Michael Edelstein, Flavius Martin, and Ah-Hyung “Alissa” Park.
UCLA Ranks Top 5 in Pitchbook 2025
Top 100 universities ranked for entrepreneurs
UCLA Rankings
#4 Top Public University Entrepreneur List (filtered by Graduate, Public Universities)
#5 Top Female Founders
#3 Top MBA Founders
UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration
Photo L to R: Amir Naiberg, AVC, CEO and President, UCLA Technology Development Group, Dr. Wong, Professor, UCLA School of Dentistry and Dong-Cheol Kim, CEO, Dongwoon Anatech
UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration to Advance Saliva-Based Cancer Detection Technology
Sponsored Research Agreement will provide up to $787,500 annually to support Dr. David T.W. Wong's Electric Field-Induced Release and Measurement (EFIRM) platform.